Filing Details
- Accession Number:
- 0001140361-13-035273
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-09-06 17:31:24
- Reporting Period:
- 2013-09-06
- Filing Date:
- 2013-09-06
- Accepted Time:
- 2013-09-06 17:31:24
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 69499 | Mylan Inc. | MYL | Pharmaceutical Preparations (2834) | 251211621 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1280753 | M Heather Bresch | 1500 Corporate Drive Canonsburg PA 15317 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2013-09-06 | 160,000 | $15.80 | 390,856 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2013-09-06 | 156,800 | $35.34 | 234,056 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2013-09-06 | 3,200 | $35.89 | 230,856 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option Right to Buy | Disposition | 2013-09-06 | 160,000 | $0.00 | 160,000 | $15.80 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2017-07-27 | No | 4 | M | Direct |
Footnotes
- The reporting person's ownership through 401(k) holdings as of September 6, 2013 was 1,157 shares.
- Represents the weighted average price of the reporting person's disposition of 156,800 shares in transactions ranging from $34.865 to $35.82.
- The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2 and 4 to this Form 4.
- Represents the weighted average price of the reporting person's disposition of 3,200 shares in transactions ranging from $35.87 to $35.895.
- This option exercise and the related sale of the underlying common stock were executed pursuant to a 10b5-1 trading plan dated August 22, 2013.
- The options vested in four (4) equal installments on July 27, 2008, July 27, 2009, July 27, 2010 and July 27, 2011.
Billionaire Hedge Funds
